MRL Ventures Fund
Venture capital · Cambridge, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio1 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Relay Therapeutics
37Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Kymera Therapeutics | Biotech | Active | — | — |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Harpoon Therapeutics | Biotech | Acquired | Oct 31, 2023 | $220.3M |
Peer ranks
Portfolio size#136
Portfolio exits#103
Raises, 12 months#88
Co-investors#50
Co-investors
- Alexandria Venture InvestmentsVenture capital2 shared
- Apple Tree PartnersVenture capital2 shared
- Bay City CapitalVenture capital2 shared
- Biotechnology Value FundVenture capital2 shared
- EcoR1 CapitalVenture capital2 shared
- Logos CapitalVenture capital2 shared
- OUP (Osage University Partners)Venture capital2 shared
- SchrödingerVenture capital2 shared
- AbbVieVenture capital1 shared
- Ascent Biomedical VenturesVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.